Gene Details



Tcf3 and homologs in 4 species are found in 815 GeneSets:


- Entrez   - Ensembl   - GeneNetwork   - STRING   - Allen Brain Atlas   - MGI   - Comparative Toxicogenomics Database  

Select gene sets below using the check boxes, and then add them to a project using the pull down below. You can also create a project using the pull down. To view a set, click on the GeneSetID:GeneSet Description shown in green below.
GS185131: GO:0044699 single-organism process
GS198398: GO:0050670 regulation of lymphocyte proliferation
GS184830: GO:0030890 positive regulation of B cell proliferation
GS202082: GO:0051254 positive regulation of RNA metabolic process
GS170466: MP:0008211 decreased mature B cell number
GS167628: MP:0005461 abnormal dendritic cell morphology
GS169127: MP:0002445 abnormal mononuclear cell differentiation
GS135258: anti-erythrocyte autoantibody modifier 3 (Aem3, Published QTL Chr 10)
GS135860: femur breaking strength 3 (Fembrs3, Published QTL Chr 10)
GS185261: GO:0051254 positive regulation of RNA metabolic process
GS204481: GO:0070665 positive regulation of leukocyte proliferation
GS186528: GO:0002684 positive regulation of immune system process
GS203018: GO:0045935 positive regulation of nucleobase-containing compound metabolic process
GS168559: MP:0002421 abnormal cell-mediated immunity
GS168327: MP:0008171 abnormal mature B cell morphology
GS193152: GO:0032946 positive regulation of mononuclear cell proliferation
GS169830: MP:0005384 cellular phenotype
GS126475: tert-Butylhydroperoxide interacting genes (MeSH:D020122) in CTD
GS191193: GO:0009607 response to biotic stimulus
GS209250: GO:0000080 G1 phase of mitotic cell cycle
GS136052: IGF-1 serum levels 2 (Igf1sl2, Published QTL Chr 10)
GS192816: GO:0070491 repressing transcription factor binding
GS196934: GO:0065008 regulation of biological quality
GS191669: GO:0001067 regulatory region nucleic acid binding
GS195061: GO:0051149 positive regulation of muscle cell differentiation
GS204642: GO:0043543 protein acylation
GS184570: GO:0016444 somatic cell DNA recombination
GS180671: GO:0044454 nuclear chromosome part
GS199273: GO:0043233 organelle lumen
GS199388: GO:0019901 protein kinase binding
GS191019: GO:0034641 cellular nitrogen compound metabolic process
GS201621: GO:0032496 response to lipopolysaccharide
GS168334: MP:0002619 abnormal lymphocyte morphology
GS187887: GO:0080090 regulation of primary metabolic process
GS168382: MP:0001231 abnormal epidermis stratum basale morphology
GS165643: MP:0011088 partial neonatal lethality
GS165859: MP:0000351 increased cell proliferation
GS166858: MP:0000685 abnormal immune system morphology
GS178814: GO:0046982 protein heterodimerization activity
GS179950: GO:0006259 DNA metabolic process
GS163965: MP:0011182 decreased hematopoietic cell number
GS165850: MP:0000352 decreased cell proliferation
GS166207: MP:0008180 abnormal marginal zone B cell morphology
GS200483: GO:0010608 posttranscriptional regulation of gene expression
GS209602: GO:0051960 regulation of nervous system development
GS166749: MP:0002221 abnormal lymph organ size
GS189669: GO:2000112 regulation of cellular macromolecule biosynthetic process
GS163010: MP:0011181 increased hematopoietic cell number
GS136165: leishmaniasis resistance 19 (Lmr19, Published QTL Chr 10)
GS206108: GO:2001141 regulation of RNA biosynthetic process
GS163376: MP:0009763 increased sensitivity to induced morbidity/mortality
GS135790: epilepsy 3 (El3, Published QTL Chr 10)
GS192017: GO:0006139 nucleobase-containing compound metabolic process
GS184571: GO:0016447 somatic recombination of immunoglobulin gene segments
GS194417: GO:0000790 nuclear chromatin
GS177404: GO:0005737 cytoplasm
GS190282: GO:0050867 positive regulation of cell activation
GS177265: GO:0048731 system development
GS207925: GO:0034645 cellular macromolecule biosynthetic process
GS201251: GO:0044424 intracellular part
GS193238: GO:0031323 regulation of cellular metabolic process
GS135751: experimental allergic encephalomyelitis susceptibility 17 (Eae17, Published QTL Chr 10)
GS178359: GO:0071840 cellular component organization or biogenesis
GS203908: GO:0016070 RNA metabolic process
GS181893: GO:0048522 positive regulation of cellular process
GS170136: MP:0008083 decreased single-positive T cell number
GS188142: GO:0048856 anatomical structure development
GS170024: MP:0011086 partial postnatal lethality
GS136910: vertebral morphology and mechanical traits 15 (Vmmt15, Published QTL Chr 10)
GS169287: MP:0005090 increased double-negative T cell number
GS164333: MP:0000516 abnormal renal/urinary system morphology
GS196988: GO:0045595 regulation of cell differentiation
GS165866: MP:0000350 abnormal cell proliferation
GS178357: GO:0071842 cellular component organization at cellular level
GS162953: MP:0002020 increased tumor incidence
GS209551: GO:0031981 nuclear lumen
GS166660: MP:0001731 abnormal postnatal growth
GS193414: GO:0044249 cellular biosynthetic process
GS205334: GO:0051090 regulation of sequence-specific DNA binding transcription factor activity
GS163243: MP:0002362 abnormal spleen marginal zone morphology
GS194283: GO:0048537 mucosal-associated lymphoid tissue development
GS197472: GO:0044451 nucleoplasm part
GS182591: GO:0019900 kinase binding
GS87096: Table S2: List of Cocaine-Treated HDAC5 KO vs. Cocaine-Treated WT Significantly Regulated Genes. [DRG] provisional
GS36044: Neocortex Gene expression correlates of Light-Dark Box Total distance traveled in light and dark compartments in Males BXD
GS208675: GO:0022403 cell cycle phase
GS167325: MP:0002144 abnormal B cell differentiation
GS182978: GO:0033993 response to lipid
GS193888: GO:0051276 chromosome organization
GS179236: GO:0048699 generation of neurons
GS190582: GO:0033152 immunoglobulin V(D)J recombination
GS188784: GO:0008134 transcription factor binding
GS178922: GO:0003700 sequence-specific DNA binding transcription factor activity
GS205659: GO:0042493 response to drug
GS177844: GO:0002377 immunoglobulin production
GS194455: GO:0051239 regulation of multicellular organismal process
GS193937: GO:0006366 transcription from RNA polymerase II promoter
GS205237: GO:0030217 T cell differentiation
GS168063: MP:0000313 abnormal cell death
GS194876: GO:0042113 B cell activation
GS198868: GO:0000786 nucleosome
GS179769: GO:0000975 regulatory region DNA binding
GS135323: apomorphine stress induced climbing 3 (Apsic3, Published QTL Chr 10)
GS162982: MP:0002357 abnormal spleen white pulp morphology
GS201367: GO:0019538 protein metabolic process
GS170415: MP:0008077 abnormal CD8-positive T cell number
GS198870: GO:0000788 nuclear nucleosome
GS208716: GO:2000026 regulation of multicellular organismal development
GS195340: GO:0045893 positive regulation of transcription, DNA-dependent
GS196808: GO:0032501 multicellular organismal process
GS178913: GO:0042221 response to chemical stimulus
GS186744: GO:0043226 organelle
GS193154: GO:0032944 regulation of mononuclear cell proliferation
GS136631: small effect CIA locus 5 (Secia5, Published QTL Chr 10)
GS182835: GO:0005622 intracellular
GS201756: GO:0042692 muscle cell differentiation
GS182703: GO:0051171 regulation of nitrogen compound metabolic process
GS195541: GO:0000278 mitotic cell cycle
GS210178: GO:0031328 positive regulation of cellular biosynthetic process
GS203482: GO:0044093 positive regulation of molecular function
GS198360: GO:0006357 regulation of transcription from RNA polymerase II promoter
GS166202: MP:0008187 absent pro-B cells
GS186790: GO:0006725 cellular aromatic compound metabolic process
GS183957: GO:0033077 T cell differentiation in thymus
GS187423: GO:0031647 regulation of protein stability
GS166265: MP:0009584 decreased keratinocyte proliferation
GS194111: GO:0097159 organic cyclic compound binding
GS167993: MP:0002403 abnormal pre-B cell morphology
GS208187: GO:0010033 response to organic substance
GS191988: GO:0070644 vitamin D response element binding
GS191271: GO:0018205 peptidyl-lysine modification
GS189141: GO:0030888 regulation of B cell proliferation
GS185545: GO:0044212 transcription regulatory region DNA binding
GS168972: MP:0008213 absent immature B cells
GS194307: GO:0016043 cellular component organization
GS197666: GO:0051249 regulation of lymphocyte activation
GS194606: GO:0001779 natural killer cell differentiation
GS180190: GO:0051329 interphase of mitotic cell cycle
GS187783: GO:0043543 protein acylation
GS205645: GO:0008134 transcription factor binding
GS197222: GO:0031435 mitogen-activated protein kinase kinase kinase binding
GS189751: GO:0050794 regulation of cellular process
GS166590: MP:0002873 normal phenotype
GS187238: GO:0030183 B cell differentiation
GS202371: GO:0044212 transcription regulatory region DNA binding
GS187343: GO:0006351 transcription, DNA-dependent
GS195668: GO:0042221 response to chemical stimulus
GS207178: GO:0050867 positive regulation of cell activation
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
GS203369: GO:0005654 nucleoplasm
GS187175: GO:0045321 leukocyte activation
GS200950: GO:0018393 internal peptidyl-lysine acetylation
GS181473: GO:0005488 binding
GS184445: GO:0044428 nuclear part
GS180036: GO:0032501 multicellular organismal process
GS187237: GO:0030182 neuron differentiation
GS192345: GO:0010628 positive regulation of gene expression
GS196930: GO:0065007 biological regulation
GS200312: GO:0019219 regulation of nucleobase-containing compound metabolic process
GS177859: GO:0045944 positive regulation of transcription from RNA polymerase II promoter
GS191150: GO:0010557 positive regulation of macromolecule biosynthetic process
GS187615: GO:0070661 leukocyte proliferation
GS198004: GO:0007399 nervous system development
GS193227: GO:0030097 hemopoiesis
GS169389: MP:0002060 abnormal skin morphology
GS191779: GO:2000026 regulation of multicellular organismal development
GS164264: MP:0002082 postnatal lethality
GS167542: MP:0001790 abnormal immune system physiology
GS167326: MP:0002145 abnormal T cell differentiation
GS184335: GO:0002200 somatic diversification of immune receptors
GS204746: GO:0080090 regulation of primary metabolic process
GS165428: MP:0005153 abnormal B cell proliferation
GS163601: MP:0002089 abnormal postnatal growth/weight/body size
GS201249: GO:0044428 nuclear part
GS196968: GO:0051329 interphase of mitotic cell cycle
GS197244: GO:0044237 cellular metabolic process
GS198456: GO:0019438 aromatic compound biosynthetic process
GS36034: Neocortex Gene expression correlates of Light-Dark Box Total distance traveled in light and dark compartments in Females & Males BXD
GS167322: MP:0003944 abnormal T cell subpopulation ratio
GS194088: GO:0003676 nucleic acid binding
GS187797: GO:0016570 histone modification
GS165527: MP:0005378 growth/size phenotype
GS178589: GO:0045893 positive regulation of transcription, DNA-dependent
GS178813: GO:0046983 protein dimerization activity
GS200286: GO:0060284 regulation of cell development
GS200351: GO:0016569 covalent chromatin modification
GS169777: MP:0002398 abnormal bone marrow cell morphology/development
GS136147: lithogenic gene 7 (Lith7, Published QTL Chr 10)
GS167503: MP:0003054 spina bifida
GS177598: GO:0043412 macromolecule modification
GS186740: GO:0043229 intracellular organelle
GS169409: MP:0004939 abnormal B cell morphology
GS196540: GO:0043565 sequence-specific DNA binding
GS166250: MP:0008247 abnormal mononuclear cell morphology
GS199538: GO:0018193 peptidyl-amino acid modification
GS188506: GO:0010467 gene expression
GS208012: GO:0044464 cell part
GS201239: GO:0046483 heterocycle metabolic process
GS136778: systolic blood pressure 1 (Sysbp1, Published QTL Chr 10)
GS192073: GO:1901576 organic substance biosynthetic process
GS188399: GO:0044238 primary metabolic process
GS162983: MP:0002356 abnormal spleen red pulp morphology
GS208060: GO:0010557 positive regulation of macromolecule biosynthetic process
GS184435: GO:0046483 heterocycle metabolic process
GS169063: MP:0005432 abnormal pro-B cell morphology
GS168422: MP:0000716 abnormal immune system cell morphology
GS195113: GO:0071841 cellular component organization or biogenesis at cellular level
GS205567: GO:0045787 positive regulation of cell cycle
GS123554: vinclozolin interacting genes (MeSH:C025643) in CTD
GS186214: GO:0048518 positive regulation of biological process
GS168152: MP:0005501 abnormal skin physiology
GS205144: GO:0048468 cell development
GS206764: GO:0048541 Peyer's patch development
GS35773: Hippocampus Gene expression correlates of CPP - Time (s) in drug-paired compartment a in Females BXD
GS166719: MP:0010678 abnormal skin adnexa morphology
GS123718: Ethinyl Estradiol interacting genes (MeSH:D004997) in CTD
GS177310: GO:1901360 organic cyclic compound metabolic process
GS167508: MP:0008761 abnormal immunoglobulin light chain V-J recombination
GS206175: GO:0051318 G1 phase
GS163241: MP:0002367 abnormal thymus lobule morphology
GS167020: MP:0003956 abnormal body size
GS162986: MP:0001802 arrested B cell differentiation
GS169535: MP:0005397 hematopoietic system phenotype
GS192959: GO:0002237 response to molecule of bacterial origin
GS169833: MP:0005380 embryogenesis phenotype
GS204096: GO:0030183 B cell differentiation
GS177902: GO:0042802 identical protein binding
GS208657: GO:0008284 positive regulation of cell proliferation
GS191151: GO:0010556 regulation of macromolecule biosynthetic process
GS196002: GO:0048699 generation of neurons
GS209282: GO:0010628 positive regulation of gene expression
GS163283: MP:0008040 decreased NK T cell number
GS197016: GO:0032991 macromolecular complex
GS178448: GO:0005634 nucleus
GS198948: GO:0006310 DNA recombination
GS199635: GO:0005622 intracellular
GS195206: GO:0002520 immune system development
GS163591: MP:0005015 increased T cell number
GS183284: GO:0003713 transcription coactivator activity
GS188798: GO:0042493 response to drug
GS208061: GO:0010556 regulation of macromolecule biosynthetic process
GS165986: MP:0008463 abnormal peripheral lymph node morphology
GS213076: Genes with suggestive difference in (B6) vs (B6PF1 + PB6F1 + PWD) comparison
GS163077: MP:0010274 increased organ/body region tumor incidence
GS187984: GO:0003682 chromatin binding
GS170419: MP:0008078 increased CD8-positive T cell number
GS168379: MP:0002151 abnormal neural tube morphology/development
GS135635: collagen induced arthritis QTL 8 (Cia8, Published QTL Chr 10)
GS165244: MP:0010771 integument phenotype
GS196941: GO:0008150 biological_process
GS164673: MP:0010296 increased hemolymphoid system tumor incidence
GS135699: directional asymmetry QTL 6 (Daq6, Published QTL Chr 10)
GS207176: GO:0050865 regulation of cell activation
GS190893: GO:0030154 cell differentiation
GS197470: GO:0044454 nuclear chromosome part
GS166564: MP:0000692 small spleen
GS201256: GO:0044422 organelle part
GS35807: Striatum Gene expression correlates of Cocaine CPP- Time (s) in drug-paired compartment a in Males BXD
GS201431: GO:0005515 protein binding
GS135438: bone mineral density 38 (Bmd38, Published QTL Chr 10)
GS165615: MP:0002123 abnormal hematopoiesis
GS136941: vertebral trabecular bone trait 9 (Vtbt9, Published QTL Chr 10)
GS209411: GO:0048869 cellular developmental process
GS187160: GO:0044707 single-multicellular organism process
GS177548: GO:0048534 hematopoietic or lymphoid organ development
GS177761: GO:0044271 cellular nitrogen compound biosynthetic process
GS177169: GO:0051276 chromosome organization
GS189309: GO:0051318 G1 phase
GS203371: GO:0002684 positive regulation of immune system process
GS168630: MP:0000377 abnormal hair follicle morphology
GS199267: GO:0043234 protein complex
GS165880: MP:0001218 thin epidermis
GS201372: GO:0016444 somatic cell DNA recombination
GS181783: GO:0010604 positive regulation of macromolecule metabolic process
GS195110: GO:0071842 cellular component organization at cellular level
GS193059: GO:0044446 intracellular organelle part
GS210181: GO:0031325 positive regulation of cellular metabolic process
GS209564: GO:0043231 intracellular membrane-bounded organelle
GS202080: GO:0051252 regulation of RNA metabolic process
GS208051: GO:0002521 leukocyte differentiation
GS184781: GO:0009617 response to bacterium
GS181609: GO:0050671 positive regulation of lymphocyte proliferation
GS169827: MP:0005387 immune system phenotype
GS204095: GO:0030182 neuron differentiation
GS167073: MP:0001926 female infertility
GS199272: GO:0043232 intracellular non-membrane-bounded organelle
GS177988: GO:0030165 PDZ domain binding
GS165181: MP:0010365 increased thymus tumor incidence
GS194524: GO:0006325 chromatin organization
GS204021: GO:0044707 single-multicellular organism process
GS205047: GO:0006807 nitrogen compound metabolic process
GS184629: GO:0005515 protein binding
GS192088: GO:0000989 transcription factor binding transcription factor activity
GS204287: GO:0031647 regulation of protein stability
GS169603: MP:0001672 abnormal embryogenesis/ development
GS164482: MP:0001216 abnormal epidermal layer morphology
GS178785: GO:0000278 mitotic cell cycle
GS188441: GO:0045165 cell fate commitment
GS135614: circulating hormone level QTL 6 (Chlq6, Published QTL Chr 10)
GS194481: GO:0019899 enzyme binding
GS183680: GO:0010608 posttranscriptional regulation of gene expression
GS186488: GO:0048513 organ development
GS170601: MP:0005621 abnormal cell physiology
GS166718: MP:0002169 no abnormal phenotype detected
GS84241: alcohol preference (Published QTL, Chr 10)
GS196806: GO:0032502 developmental process
GS204842: GO:0003682 chromatin binding
GS206618: GO:0050793 regulation of developmental process
GS166215: MP:0008188 abnormal transitional stage B cell morphology
GS168273: MP:0002432 abnormal CD4-positive T cell morphology
GS181215: GO:0007399 nervous system development
GS186642: GO:0051707 response to other organism
GS201592: GO:0009617 response to bacterium
GS189941: GO:0043425 bHLH transcription factor binding
GS164022: MP:0008246 abnormal leukocyte morphology
GS166587: MP:0003643 spleen atrophy
GS194586: GO:0002376 immune system process
GS209009: GO:1901576 organic substance biosynthetic process
GS182705: GO:0051173 positive regulation of nitrogen compound metabolic process
GS204036: GO:0045321 leukocyte activation
GS181102: GO:0043228 non-membrane-bounded organelle
GS164742: MP:0001732 postnatal growth retardation
GS166405: MP:0002111 abnormal tail morphology
GS197319: GO:0003712 transcription cofactor activity
GS182194: GO:0005667 transcription factor complex
GS189546: GO:0002440 production of molecular mediator of immune response
GS170545: MP:0002022 increased lymphoma incidence
GS207457: GO:0002562 somatic diversification of immune receptors via germline recombination within a single locus
GS135326: age related thymic involution 2 (Arti2, Published QTL Chr 10)
GS167098: MP:0001819 abnormal immune cell physiology
GS177356: GO:0003674 molecular_function
GS203590: GO:0043229 intracellular organelle
GS199032: GO:0036211 protein modification process
GS177717: GO:0051239 regulation of multicellular organismal process
GS177309: GO:1901363 heterocyclic compound binding
GS196837: GO:0042110 T cell activation
GS136072: insulin QTL 4 (Insq4, Published QTL Chr 10)
GS188410: GO:0032774 RNA biosynthetic process
GS192471: GO:0048869 cellular developmental process
GS191727: GO:0008283 cell proliferation
GS198399: GO:0050671 positive regulation of lymphocyte proliferation
GS198991: GO:0005667 transcription factor complex
GS210095: GO:0032943 mononuclear cell proliferation
GS182740: GO:0018193 peptidyl-amino acid modification
GS203072: GO:0090304 nucleic acid metabolic process
GS180063: GO:0042110 T cell activation
GS168988: MP:0005089 decreased double-negative T cell number
GS177382: GO:0097159 organic cyclic compound binding
GS201253: GO:0044427 chromosomal part
GS191662: GO:0033151 V(D)J recombination
GS202077: GO:0051251 positive regulation of lymphocyte activation
GS202813: GO:0006475 internal protein amino acid acetylation
GS168848: MP:0002452 abnormal antigen presenting cell physiology
GS205543: GO:0070013 intracellular organelle lumen
GS177903: GO:0042803 protein homodimerization activity
GS168330: MP:0008176 abnormal germinal center B cell morphology
GS170413: MP:0008071 absent B cells
GS187751: GO:0019222 regulation of metabolic process
GS183491: GO:0060284 regulation of cell development
GS196719: GO:0006259 DNA metabolic process
GS191144: GO:0002521 leukocyte differentiation
GS136675: skull morphology 14 (Skull14, Published QTL Chr 10)
GS180238: GO:0032993 protein-DNA complex
GS136235: mandible length 9 (Manln9, Published QTL Chr 10)
GS135606: circulating hormone level QTL 15 (Chlq15, Published QTL Chr 10)
GS193237: GO:0031325 positive regulation of cellular metabolic process
GS195214: GO:0009987 cellular process
GS207177: GO:0050864 regulation of B cell activation
GS163557: MP:0008038 abnormal NK T cell number
GS163934: MP:0001764 abnormal homeostasis
GS184452: GO:0044422 organelle part
GS204204: GO:0006351 transcription, DNA-dependent
GS180034: GO:0032502 developmental process
GS195112: GO:0071840 cellular component organization or biogenesis
GS200648: GO:0044260 cellular macromolecule metabolic process
GS165525: MP:0010768 mortality/aging
GS177863: GO:0001779 natural killer cell differentiation
GS180155: GO:0065009 regulation of molecular function
GS206571: GO:0045666 positive regulation of neuron differentiation
GS169025: MP:0001657 abnormal induced morbidity/mortality
GS188478: GO:0051090 regulation of sequence-specific DNA binding transcription factor activity
GS194602: GO:0045944 positive regulation of transcription from RNA polymerase II promoter
GS165649: MP:0008127 decreased dendritic cell number
GS200755: GO:0033077 T cell differentiation in thymus
GS125002: Topotecan interacting genes (MeSH:D019772) in CTD
GS185259: GO:0051252 regulation of RNA metabolic process
GS203642: GO:0006725 cellular aromatic compound metabolic process
GS190280: GO:0050865 regulation of cell activation
GS188381: GO:0030217 T cell differentiation
GS168174: MP:0001919 abnormal reproductive system physiology
GS181133: GO:0046649 lymphocyte activation
GS207923: GO:0034641 cellular nitrogen compound metabolic process
GS165265: MP:0005014 increased B cell number
GS198263: GO:0005488 binding
GS196935: GO:0051325 interphase
GS194040: GO:1901360 organic cyclic compound metabolic process
GS193009: GO:0042127 regulation of cell proliferation
GS86932: Table S3: CORTEX 17K MICROARRAY [DRG]
GS192918: GO:0050896 response to stimulus
GS184574: GO:0043967 histone H4 acetylation
GS164782: MP:0009543 abnormal thymus corticomedullary boundary morphology
GS190067: GO:0018130 heterocycle biosynthetic process
GS165524: MP:0010769 abnormal survival
GS180526: GO:0003712 transcription cofactor activity
GS170417: MP:0008075 decreased CD4-positive T cell number
GS163280: MP:0008043 abnormal NK cell number
GS208597: GO:0033151 V(D)J recombination
GS170092: MP:0000709 enlarged thymus
GS205266: GO:0032774 RNA biosynthetic process
GS170617: MP:0005022 abnormal immature B cell morphology
GS165243: MP:0010770 preweaning lethality
GS164429: MP:0010288 increased gland tumor incidence
GS177959: GO:0051726 regulation of cell cycle
GS167999: MP:0002408 abnormal double-positive T cell morphology
GS125403: Diethylstilbestrol interacting genes (MeSH:D004054) in CTD
GS179777: GO:0043565 sequence-specific DNA binding
GS177784: GO:0006325 chromatin organization
GS205691: GO:0022008 neurogenesis
GS194267: GO:0043170 macromolecule metabolic process
GS210357: GO:0044249 cellular biosynthetic process
GS180452: GO:0044237 cellular metabolic process
GS183630: GO:0002682 regulation of immune system process
GS178453: GO:0002520 immune system development
GS164694: MP:0005048 thrombosis
GS168270: MP:0002435 abnormal effector T cell morphology
GS182469: GO:0043234 protein complex
GS195570: GO:0046983 protein dimerization activity
GS206953: GO:0018130 heterocycle biosynthetic process
GS203057: GO:0048518 positive regulation of biological process
GS165798: MP:0005367 renal/urinary system phenotype
GS167589: MP:0005016 decreased lymphocyte cell number
GS194499: GO:0044271 cellular nitrogen compound biosynthetic process
GS123768: Cyclosporine interacting genes (MeSH:D016572) in CTD
GS180164: GO:0008150 biological_process
GS177357: GO:0003676 nucleic acid binding
GS168995: MP:0009642 abnormal blood homeostasis
GS177531: GO:0043170 macromolecule metabolic process
GS188287: GO:0048468 cell development
GS196986: GO:0045597 positive regulation of cell differentiation
GS208674: GO:0022402 cell cycle process
GS206415: GO:0002440 production of molecular mediator of immune response
GS209023: GO:0000989 transcription factor binding transcription factor activity
GS189746: GO:0050793 regulation of developmental process
GS205255: GO:0044238 primary metabolic process
GS192660: GO:0051960 regulation of nervous system development
GS167575: MP:0005013 increased lymphocyte cell number
GS170543: MP:0002024 T cell derived lymphoma
GS177214: GO:0006366 transcription from RNA polymerase II promoter
GS180236: GO:0032991 macromolecular complex
GS164776: MP:0008178 decreased germinal center B cell number
GS207858: GO:0009059 macromolecule biosynthetic process
GS87041: Table S3: List of Cocaine-Treated HDAC5 KO vs. Saline-Treated HDAC5 KO Significantly Regulated Genes. [DRG] provisional
GS163560: MP:0008037 abnormal T cell morphology
GS177813: GO:0031974 membrane-enclosed lumen
GS184218: GO:0071704 organic substance metabolic process
GS164605: MP:0002339 abnormal lymph node morphology
GS192610: GO:0031981 nuclear lumen
GS200602: GO:0044267 cellular protein metabolic process
GS163568: MP:0002551 abnormal blood coagulation
GS187616: GO:0070663 regulation of leukocyte proliferation
GS200080: GO:0003713 transcription coactivator activity
GS136454: postnatal body weight growth 16 (Pbwg16, Published QTL Chr 10)
GS183514: GO:0019219 regulation of nucleobase-containing compound metabolic process
GS866: Linear decrease in expression in both Pax6 (Sey) mutants and controls.
GS183848: GO:0044260 cellular macromolecule metabolic process
GS186757: GO:0034654 nucleobase-containing compound biosynthetic process
GS164257: MP:0002085 abnormal embryonic tissue morphology
GS169371: MP:0000929 open neural tube
GS167566: MP:0005018 decreased T cell number
GS198685: GO:0048522 positive regulation of cellular process
GS170086: MP:0000703 abnormal thymus morphology
GS201949: GO:0044699 single-organism process
GS136720: susceptibility to lung cancer 22 (Sluc22, Published QTL Chr 10)
GS170089: MP:0000706 small thymus
GS208954: GO:0006139 nucleobase-containing compound metabolic process
GS202902: GO:0050871 positive regulation of B cell activation
GS186526: GO:0005654 nucleoplasm
GS135645: cardiac modifier of nmd 2 (Cmn2, Published QTL Chr 10)
GS190950: GO:0009059 macromolecule biosynthetic process
GS181568: GO:0006357 regulation of transcription from RNA polymerase II promoter
GS164320: MP:0003861 abnormal nervous system development
GS178461: GO:0009987 cellular process
GS163966: MP:0002098 abnormal vibrissa morphology
GS192624: GO:0043231 intracellular membrane-bounded organelle
GS205296: GO:0045165 cell fate commitment
GS165620: MP:0008125 abnormal dendritic cell number
GS186743: GO:0043227 membrane-bounded organelle
GS124185: Plant Extracts interacting genes (MeSH:D010936) in CTD
GS136079: juvenile cystic kidney modifier 1 (Jckm1, Published QTL Chr 10)
GS167996: MP:0002407 abnormal double-negative T cell morphology
GS169973: MP:0002006 tumorigenesis
GS179830: GO:0006464 cellular protein modification process
GS201373: GO:0016447 somatic recombination of immunoglobulin gene segments
GS193268: GO:0005575 cellular_component
GS194039: GO:1901363 heterocyclic compound binding
GS170546: MP:0002021 increased incidence of induced tumors
GS188190: GO:0006807 nitrogen compound metabolic process
GS135450: bone length and organs 6 (Bod6, Published QTL Chr 10)
GS194646: GO:0042803 protein homodimerization activity
GS186246: GO:0018394 peptidyl-lysine acetylation
GS200436: GO:0030101 natural killer cell activation
GS207797: GO:0030154 cell differentiation
GS207581: GO:0007275 multicellular organismal development
GS184149: GO:0018393 internal peptidyl-lysine acetylation
GS191721: GO:0008284 positive regulation of cell proliferation
GS205002: GO:0048856 anatomical structure development
GS164881: MP:0005068 abnormal NK cell morphology
GS170364: MP:0000715 decreased thymocyte number
GS166746: MP:0002224 abnormal spleen size
GS86494: Table S1: Hippocampus 17 K microarray data. [DRG]
GS207857: GO:0009058 biosynthetic process
GS170358: MP:0001823 thymus hypoplasia
GS192986: GO:0006996 organelle organization
GS201142: GO:0002200 somatic diversification of immune receptors
GS136650: skeletal size (tail length) 4 (Skl4, Published QTL Chr 10)
GS165466: MP:0003632 abnormal nervous system morphology
GS163956: MP:0011180 abnormal hematopoietic cell number
GS169835: MP:0005389 reproductive system phenotype
GS200490: GO:0061061 muscle structure development
GS190564: GO:0002562 somatic diversification of immune receptors via germline recombination within a single locus
GS203238: GO:0000228 nuclear chromosome
GS201023: GO:0071704 organic substance metabolic process
GS196595: GO:0006464 cellular protein modification process
GS166706: MP:0002166 altered tumor susceptibility
GS184566: GO:0019538 protein metabolic process
GS201088: GO:0002326 B cell lineage commitment
GS201191: GO:0042100 B cell proliferation
GS191106: GO:0044464 cell part
GS177570: GO:0016043 cellular component organization
GS180431: GO:0031435 mitogen-activated protein kinase kinase kinase binding
GS186227: GO:0090304 nucleic acid metabolic process
GS127205: Tamoxifen interacting genes (MeSH:D013629) in CTD
GS167991: MP:0002401 abnormal lymphopoiesis
GS204612: GO:0019222 regulation of metabolic process
GS210168: GO:0030098 lymphocyte differentiation
GS167507: MP:0008760 abnormal immunoglobulin heavy chain V(D)J recombination
GS177862: GO:0001775 cell activation
GS178247: GO:0070888 E-box binding
GS170460: MP:0008217 abnormal B cell activation
GS84243: METH responses for home cage activity (Published QTL, Chr 10)
GS183635: GO:0030101 natural killer cell activation
GS192944: GO:0050767 regulation of neurogenesis
GS194555: GO:0031974 membrane-enclosed lumen
GS184449: GO:0044427 chromosomal part
GS191738: GO:0022403 cell cycle phase
GS164133: MP:0005076 abnormal cell differentiation
GS190772: GO:0002696 positive regulation of leukocyte activation
GS177680: GO:0000790 nuclear chromatin
GS210099: GO:0032944 regulation of mononuclear cell proliferation
GS181074: GO:0043966 histone H3 acetylation
GS169133: MP:0002442 abnormal leukocyte physiology
GS206601: GO:0050821 protein stabilization
GS203607: GO:0034654 nucleobase-containing compound biosynthetic process
GS135360: B.burgdorferi-associated arthritis 18 (Bbaa18, Published QTL Chr 10)
GS201376: GO:0043967 histone H4 acetylation
GS203494: GO:0051704 multi-organism process
GS185585: GO:0044710 single-organism metabolic process
GS187708: GO:0009893 positive regulation of metabolic process
GS209762: GO:0070491 repressing transcription factor binding
GS204232: GO:0001071 nucleic acid binding transcription factor activity
GS135778: endothelin receptor type B modifier 1 (Ednrbm1, Published QTL Chr 10)
GS187618: GO:0070665 positive regulation of leukocyte proliferation
GS168502: MP:0002058 neonatal lethality
GS36064: Neocortex Gene expression correlates of Light-Dark Box Transitions in Females & Males BXD
GS136122: life span 2 (Lifespan2, Published QTL Chr 10)
GS205338: GO:0051094 positive regulation of developmental process
GS184809: GO:0032496 response to lipopolysaccharide
GS182595: GO:0019904 protein domain specific binding
GS170084: MP:0000701 abnormal lymph node size
GS136154: limb length QTL 4 (Lmblgq4, Published QTL Chr 10)
GS188482: GO:0051094 positive regulation of developmental process
GS180156: GO:0065008 regulation of biological quality
GS204479: GO:0070663 regulation of leukocyte proliferation
GS192089: GO:0000988 protein binding transcription factor activity
GS197892: GO:0043228 non-membrane-bounded organelle
GS165904: MP:0009622 absent inguinal lymph nodes
GS192256: GO:0007049 cell cycle
GS206822: GO:0043425 bHLH transcription factor binding
GS195643: GO:0003677 DNA binding
GS198572: GO:0010604 positive regulation of macromolecule metabolic process
GS209928: GO:0006996 organelle organization
GS167077: MP:0008082 increased single-positive T cell number
GS196532: GO:0000975 regulatory region DNA binding
GS202415: GO:0044710 single-organism metabolic process
GS206544: GO:2000112 regulation of cellular macromolecule biosynthetic process
GS187798: GO:0016573 histone acetylation
GS170411: MP:0008073 abnormal CD4-positive T cell number
GS194133: GO:0005737 cytoplasm
GS167627: MP:0005460 abnormal leukopoiesis
GS199501: GO:0051173 positive regulation of nitrogen compound metabolic process
GS185489: GO:0046651 lymphocyte proliferation
GS184130: GO:0006473 protein acetylation
GS206329: GO:0060255 regulation of macromolecule metabolic process
GS184280: GO:0002326 B cell lineage commitment
GS195199: GO:0005634 nucleus
GS193234: GO:0031328 positive regulation of cellular biosynthetic process
GS163728: MP:0005154 increased B cell proliferation
GS192315: GO:0000080 G1 phase of mitotic cell cycle
GS208927: GO:0070644 vitamin D response element binding
GS163803: MP:0003631 nervous system phenotype
GS207474: GO:0033152 immunoglobulin V(D)J recombination
GS169285: MP:0005092 decreased double-positive T cell number
GS136004: hepatocarcinogen resistance 2 (Hpcr2, Published QTL Chr 10)
GS189240: GO:2001141 regulation of RNA biosynthetic process
GS170020: MP:0008215 decreased immature B cell number
GS208914: GO:0051091 positive regulation of sequence-specific DNA binding transcription factor activity
GS135312: aortic lesion size 1 (Aorls1, Published QTL Chr 10)
GS186178: GO:0045935 positive regulation of nucleobase-containing compound metabolic process
GS170647: MP:0002340 abnormal axillary lymph node morphology
GS181608: GO:0050670 regulation of lymphocyte proliferation
GS202313: GO:0046651 lymphocyte proliferation
GS190281: GO:0050864 regulation of B cell activation
GS209951: GO:0042127 regulation of cell proliferation
GS195571: GO:0046982 protein heterodimerization activity
GS204478: GO:0070661 leukocyte proliferation
GS184384: GO:0042100 B cell proliferation
GS185492: GO:0050789 regulation of biological process
GS167714: MP:0002414 abnormal myeloblast morphology/development
GS167067: MP:0002217 small lymph nodes
GS213077: Genes with suggestive difference in (PWD) vs (PB6F1 + B6PF1 + B6) comparison
GS186645: GO:0051704 multi-organism process
GS210170: GO:0030097 hemopoiesis
GS185975: GO:0006475 internal protein amino acid acetylation
GS209902: GO:0002237 response to molecule of bacterial origin
GS182590: GO:0019901 protein kinase binding
GS191975: GO:0051091 positive regulation of sequence-specific DNA binding transcription factor activity
GS193991: GO:0048731 system development
GS201642: GO:0030890 positive regulation of B cell proliferation
GS163294: MP:0000218 increased leukocyte cell number
GS182153: GO:0006310 DNA recombination
GS165209: MP:0005010 abnormal CD8-positive T cell morphology
GS181667: GO:0019438 aromatic compound biosynthetic process
GS188511: GO:0010468 regulation of gene expression
GS34223: Neocortex Gene expression correlates of Light-Dark Box Total distance traveled in light compartment in Males BXD
GS165099: MP:0008209 decreased pre-B cell number
GS125548: Doxorubicin interacting genes (MeSH:D004317) in CTD
GS84242: ethanol withdrawal (Published QTL, Chr 10)
GS124083: polyphenols interacting genes (MeSH:C025299) in CTD
GS169767: MP:0002396 abnormal hematopoietic system morphology/development
GS184447: GO:0044424 intracellular part
GS193236: GO:0031326 regulation of cellular biosynthetic process
GS184569: GO:0016445 somatic diversification of immunoglobulins
GS207673: GO:0002694 regulation of leukocyte activation
GS209863: GO:0050896 response to stimulus
GS166513: MP:0008195 abnormal antigen presenting cell morphology
GS169880: MP:0009676 abnormal hemostasis
GS163080: MP:0010273 increased classified tumor incidence
GS178360: GO:0071841 cellular component organization or biogenesis at cellular level
GS135339: atherosclerosis 17 (Ath17, Published QTL Chr 10)
GS191021: GO:0034645 cellular macromolecule biosynthetic process
GS199499: GO:0051171 regulation of nitrogen compound metabolic process
GS203335: GO:0048513 organ development
GS188684: GO:0070013 intracellular organelle lumen
GS178127: GO:0042113 B cell activation
GS166712: MP:0002161 abnormal fertility/fecundity
GS163589: MP:0005017 decreased B cell number
GS163240: MP:0002364 abnormal thymus size
GS193225: GO:0030098 lymphocyte differentiation
GS203092: GO:0018394 peptidyl-lysine acetylation
GS36074: Neocortex Gene expression correlates of Light-Dark Box Transitions in Males BXD
GS182475: GO:0043233 organelle lumen
GS182234: GO:0036211 protein modification process
GS164534: MP:0002019 abnormal tumor incidence
GS210212: GO:0005575 cellular_component
GS195291: GO:0006355 regulation of transcription, DNA-dependent
GS204656: GO:0016570 histone modification
GS135500: brain size control 1 (Bsc1, Published QTL Chr 10)
GS205369: GO:0010468 regulation of gene expression
GS164304: MP:0004808 abnormal hematopoietic stem cell morphology
GS163845: MP:0000238 absent pre-B cells
GS188762: GO:0009889 regulation of biosynthetic process
GS206623: GO:0050794 regulation of cellular process
GS124805: decitabine interacting genes (MeSH:C014347) in CTD
GS197924: GO:0046649 lymphocyte activation
GS177547: GO:0048537 mucosal-associated lymphoid tissue development
GS194995: GO:0070888 E-box binding
GS186395: GO:0000228 nuclear chromosome
GS189724: GO:0050821 protein stabilization
GS125820: 4-hydroxy-2-nonenal interacting genes (MeSH:C027576) in CTD
GS187370: GO:0001071 nucleic acid binding transcription factor activity
GS163818: MP:0002722 abnormal immune system organ morphology
GS197864: GO:0043966 histone H3 acetylation
GS182076: GO:0000786 nucleosome
GS164261: MP:0002081 perinatal lethality
GS194038: GO:1901362 organic cyclic compound biosynthetic process
GS194703: GO:0051726 regulation of cell cycle
GS199778: GO:0033993 response to lipid
GS197018: GO:0032993 protein-DNA complex
GS206007: GO:0030888 regulation of B cell proliferation
GS183803: GO:0044267 cellular protein metabolic process
GS193150: GO:0032943 mononuclear cell proliferation
GS177742: GO:0019899 enzyme binding
GS135247: adiposity 15 (Adip15, Published QTL Chr 10)
GS136099: long bones 9 (Lbn9, Published QTL Chr 10)
GS203491: GO:0051707 response to other organism
GS200930: GO:0006473 protein acetylation
GS164588: MP:0003051 curly tail
GS168294: MP:0003699 abnormal female reproductive system physiology
GS164263: MP:0002083 premature death
GS210180: GO:0031326 regulation of cellular biosynthetic process
GS189880: GO:0048541 Peyer's patch development
GS135327: arthropathy in MRL and DBA/1 mice 1 (Artmd1, Published QTL Chr 10)
GS182834: GO:0005623 cell
GS205622: GO:0009889 regulation of biosynthetic process
GS189460: GO:0060255 regulation of macromolecule metabolic process
GS168845: MP:0002459 abnormal B cell physiology
GS182474: GO:0043232 intracellular non-membrane-bounded organelle
GS168012: MP:0010832 lethality during fetal growth through weaning
GS201371: GO:0016445 somatic diversification of immunoglobulins
GS208190: GO:0018205 peptidyl-lysine modification
GS167075: MP:0001924 infertility
GS169963: MP:0001284 absent vibrissae
GS178537: GO:0006355 regulation of transcription, DNA-dependent
GS185937: GO:0005694 chromosome
GS196943: GO:0008152 metabolic process
GS190770: GO:0002694 regulation of leukocyte activation
GS199634: GO:0005623 cell
GS164136: MP:0000001 mammalian phenotype
GS191737: GO:0022402 cell cycle process
GS187045: GO:0016070 RNA metabolic process
GS210097: GO:0032946 positive regulation of mononuclear cell proliferation
GS210182: GO:0031323 regulation of cellular metabolic process
GS163026: MP:0000221 decreased leukocyte cell number
GS208107: GO:0009607 response to biotic stimulus
GS170761: MP:0009628 absent brachial lymph nodes
GS196933: GO:0065009 regulation of molecular function
GS206569: GO:0045664 regulation of neuron differentiation
GS166683: MP:0005231 abnormal brachial lymph node morphology
GS180206: GO:0045597 positive regulation of cell differentiation
GS190682: GO:0007275 multicellular organismal development
GS182078: GO:0000788 nuclear nucleosome
GS168551: MP:0002429 abnormal blood cell morphology/development
GS166518: MP:0008190 decreased transitional stage B cell number
GS182074: GO:0000785 chromatin
GS168560: MP:0002420 abnormal adaptive immunity
GS207675: GO:0002696 positive regulation of leukocyte activation
GS180208: GO:0045595 regulation of cell differentiation
GS188826: GO:0022008 neurogenesis
GS170138: MP:0008081 abnormal single-positive T cell number
GS170107: MP:0003720 abnormal neural tube closure
GS204568: GO:0009893 positive regulation of metabolic process
GS163297: MP:0000217 abnormal leukocyte cell number
GS177843: GO:0002376 immune system process
GS183552: GO:0016568 chromatin modification
GS168118: MP:0001191 abnormal skin condition
GS200350: GO:0016568 chromatin modification
GS202775: GO:0005694 chromosome
GS194645: GO:0042802 identical protein binding
GS180157: GO:0051325 interphase
GS180152: GO:0065007 biological regulation
GS189694: GO:0045666 positive regulation of neuron differentiation
GS165536: MP:0005371 limbs/digits/tail phenotype
GS165397: MP:0001265 decreased body size
GS170465: MP:0008210 increased mature B cell number
GS169485: MP:0000726 absent lymphocyte
GS194284: GO:0048534 hematopoietic or lymphoid organ development
GS189692: GO:0045664 regulation of neuron differentiation
GS163286: MP:0008045 decreased NK cell number
GS188708: GO:0045787 positive regulation of cell cycle
GS208664: GO:0008283 cell proliferation
GS169173: MP:0006387 abnormal T cell number
GS186633: GO:0044093 positive regulation of molecular function
GS203594: GO:0043226 organelle
GS200432: GO:0002682 regulation of immune system process
GS205364: GO:0010467 gene expression
GS136397: organ weight 6 (Org6, Published QTL Chr 10)
GS185256: GO:0051251 positive regulation of lymphocyte activation
GS163450: MP:0001199 thin skin
GS194587: GO:0002377 immunoglobulin production
GS136076: insulin QTL 9 (Insq9, Published QTL Chr 10)
GS163559: MP:0008036 abnormal NK T cell morphology
GS163639: MP:0008208 decreased pro-B cell number
GS190949: GO:0009058 biosynthetic process
GS165537: MP:0005376 homeostasis/metabolism phenotype
GS165741: MP:0008475 intermingled spleen red and white pulp
GS198866: GO:0000785 chromatin
GS204657: GO:0016573 histone acetylation
GS203593: GO:0043227 membrane-bounded organelle
GS201265: GO:0009891 positive regulation of biosynthetic process
GS209887: GO:0050767 regulation of neurogenesis
GS177308: GO:1901362 organic cyclic compound biosynthetic process
GS127127: Benzo(a)pyrene interacting genes (MeSH:D001564) in CTD
GS166271: MP:0009582 abnormal keratinocyte proliferation
GS210000: GO:0044446 intracellular organelle part
GS168370: MP:0003453 abnormal keratinocyte physiology
GS168844: MP:0002458 abnormal B cell number
GS194605: GO:0001775 cell activation
GS202316: GO:0050789 regulation of biological process
GS194087: GO:0003674 molecular_function
GS191268: GO:0010033 response to organic substance
GS184461: GO:0009891 positive regulation of biosynthetic process
GS199389: GO:0019900 kinase binding
GS121343: Flavonoids interacting genes (MeSH:D005419) in CTD
GS178885: GO:0003677 DNA binding
GS167321: MP:0003945 abnormal lymphocyte physiology
GS135585: cholesterol absorption 2 (Chab2, Published QTL Chr 10)
GS180875: GO:0051249 regulation of lymphocyte activation
GS162979: MP:0002353 abnormal inguinal lymph node morphology
GS194336: GO:0043412 macromolecule modification
GS180166: GO:0008152 metabolic process
GS183553: GO:0016569 covalent chromatin modification
GS166208: MP:0008181 increased marginal zone B cell number
GS168347: MP:0008755 abnormal immunoglobulin V(D)J recombination
GS180673: GO:0044451 nucleoplasm part
GS209024: GO:0000988 protein binding transcription factor activity
GS170362: MP:0000717 abnormal lymphocyte cell number
GS195678: GO:0003700 sequence-specific DNA binding transcription factor activity
GS208604: GO:0001067 regulatory region nucleic acid binding
GS166862: MP:0000689 abnormal spleen morphology
GS136151: "lupus in MRL and B6 F2 cross, QTL 4" (Lmb4, Published QTL Chr 10)
GS195059: GO:0051147 regulation of muscle cell differentiation
GS165688: MP:0009630 absent axillary lymph nodes
GS168628: MP:0000378 absent hair follicles
GS186071: GO:0050871 positive regulation of B cell activation
GS209190: GO:0007049 cell cycle